SCHEDULE 13G 0000315066 XXXXXXXX LIVE COMMON STOCK 06/28/2024 0001885522 Neumora Therapeutics, Inc. 640979100 490 ARSENAL WAY, SUITE 200 WATERTOWN MA 02472 Rule 13d-1(c) FMR LLC DE 8622140.00 0.00 8622468.00 0.00 8622468.00 5.4 HC Abigail P. Johnson X1 0.00 0.00 8622468.00 0.00 8622468.00 5.4 IN Neumora Therapeutics, Inc. 490 ARSENAL WAY, SUITE 200, WATERTOWN, MASSACHUSETTS, 02472. FMR LLC 245 Summer Street, Boston, Massachusetts 02210 Not applicable Y 8,622,468 5.405 Please see the responses to Items 5 and 6 on the cover page 0 8,622,468 0 Y N N One or more other persons are known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the COMMON STOCK of NEUMORA THERAPEUTICS INC. No one other person's interest in the COMMON STOCK of NEUMORA THERAPEUTICS INC is more than five percent of the total outstanding COMMON STOCK. N See attached Exhibit 99. Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. Please see Exhibit 99 for 13d-1(k) (1) agreement. FMR LLC Richard Bourgelas Duly authorized under Power of Attorney effective as of May 23, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries* 07/05/2024 Abigail P. Johnson Richard Bourgelas Duly authorized under Power of Attorney effective as of May 23, 2023, by and on behalf of Abigail P. Johnson* 07/05/2024 * This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on August 8, 2023, accession number: 0000315066-23-002397.